Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Konstantin Poukalov currently holds 30,000 shares of Landos Biopharma, Inc. (LABP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Konstantin Poukalov has been a net buyer of LABP stock. They have purchased $23.2M and sold $0 worth of shares.
Konstantin Poukalov's most recent insider trade was on Jun 13, 2024, when they sold 30,000 shares at $0.00 per share.
Konstantin Poukalov serves as Executive at Landos Biopharma, Inc. (LABP). They have executed 16 insider transactions totaling $23.2M over their tenure at the company.
Konstantin Poukalov holds the position of Executive at Landos Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Konstantin Poukalov has shown a buying trading pattern, with $23.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Konstantin Poukalov was on Feb 8, 2021, when they purchased $20.0M worth of LABP shares. This transaction involved 1,250,000 shares at $16.00 per share.
Konstantin Poukalov currently owns 30,000 shares of Landos Biopharma, Inc. (LABP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Konstantin Poukalov's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Konstantin Poukalov has 16 Form 4 filings on record as an insider at Landos Biopharma, Inc..
Set alerts for Konstantin Poukalov and 40,000+ other insiders.